Biomedical Engineering Reference
In-Depth Information
mechanisms for retinal diseases and glaucoma.
Nat Rev Drug Discov 11(7):541-559
6. Clark AF, Yorio T (2003) Ophthalmic drug
discovery. Nat Rev Drug Discov 2(6):448-459
7. Hosoya K, Tachikawa M (2012) The inner
blood-retinal barrier: molecular structure and
transport biology. Adv Exp Med Biol
763:85-104
8. Hosoya K, Yamamoto A, Akanuma S, Tachi-
kawa M (2010) Lipophilicity and transporter
influence on blood-retinal barrier permeability:
a comparison with blood-brain barrier perme-
ability. Pharm Res 27(12):2715-2724
9. Runkle EA, Antonetti DA (2011) The blood-
retinal barrier: structure and functional signifi-
cance. Methods Mol Biol 686:133-148
10. Simo R, Villarroel M, Corraliza L, Hernandez
C, Garcia-Ramirez M (2010) The retinal pig-
ment epithelium: something more than a con-
stituent of the blood-retinal barrier—
implications for the pathogenesis of diabetic
retinopathy. J Biomed Biotechnol 201:190724
11. Stewart PA, Tuor UI (1994) Blood-eye
barriers in the rat: correlation of ultrastructure
with
function.
J Comp Neurol
340
(4):566-576
12. Kubo Y, Kusagawa Y, Tachikawa M, Akanuma
S, Hosoya K (2013) Involvement of a novel
organic cation transporter in verapamil trans-
port across the inner blood-retinal barrier.
Pharm Res 30(3):847-856
13. Hosoya K, Tachikawa M (2009) Inner blood-
retinal barrier transporters: role of retinal drug
delivery. Pharm Res 26(9):2055-2065
14. Kubo Y, Shimizu Y, Kusagawa Y, Akanuma
SI, Hosoya KI (2013) Propranolol transport
across the inner blood-retinal barrier:
potential involvement of a novel organic
cation transporter.
J Pharm Sci 102(9):
3332-3342
15. Kubo Y, Hosoya K (2012) Inner blood-retinal
barrier transporters: relevance to diabetic reti-
nopathy. In: Ols MS (ed) Diabetic retinopathy.
InTech, Croatia, pp 91-108
